Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
DAYTON, Ohio – November 11, 2014 – Duke University Hospital has adopted Riverain’s ClearRead Bone Suppression, ClearRead +Detect, and ClearRead +Confirm software products as a way to extend the diagnostic potential of the world’s most commonly performed imaging procedure, the chest x-ray.
ClearRead technology helps radiologists detect lung nodules and other serious medical conditions by transforming a traditional chest x-ray into a soft tissue image without the ribs and clavicle bones. These structures commonly obscure abnormalities. There are no additional tests or radiation exposure for patients, and no imaging machines or hardware for the hospital to buy or house to achieve the soft tissue image.
As a part of their mission to provide “compassionate and state-of-the-art radiologic care and service to their patients and referring physicians,” Duke University Hospital has adopted this technology as a part of their comprehensive lung disease program.
“The ClearRead Bone Suppression technology allows us to get more out of our existing chest radiographs, without additional time or risk to the patient,” said Dr. Jared Christensen, Assistant Professor of Radiology, Division Chief of Cardiothoracic Imaging, and Director of the Duke Lung Screening Program. “The Riverain technology helps us make the correct diagnosis more quickly and confidently than ever before.”
With a greater emphasis on preventative care and earlier detection, sites across the globe see the diagnostic potential in the ClearRead Suite.